Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Victor Augusto Rodovalho Fava"'
Autor:
Eduardo Jorge Muniz Magalhães, Luciana Maria Sarin, Lorena Catarina Del Sant, Ana Cecília Lucchese, Carolina Nakahira, Marco Aurélio Tuena, Camila Brito Puertas, Victor Augusto Rodovalho Fava, Rodrigo Simonini Delfino, Juliana Surjan, Matheus Souza Steglich, Matheus Ghossain Barbosa, Guilherme Abdo, José Alberto Del Porto, Charles B. Nemeroff, Hugo Cogo-Moreira, Acioly Luiz Tavares Lacerda, Andrea Feijo Mello
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Background: A history of child sexual abuse (CSA) is related to higher suicide rates and poor treatment outcomes in depressed adult patients. Twenty years after the first study investigating the effects of ketamine/esketamine on depression and suicid
Externí odkaz:
https://doaj.org/article/b9638f2dcfc5465186e6869dc8fd3f86
Autor:
Matheus Ghossain Barbosa, Luciana Maria Sarin, Marco Aurélio Tuena, Lorena Catarina Del Sant, Carolina Nakahira, Eduardo Jorge Muniz Magalhães, Victor Augusto Rodovalho Fava, Rodrigo Simonini Delfino, Matheus Souza Steglich, Camila Puertas, Ana Cecília Lucchese, Juliana Canada Surjan, Guilherme Lozi Abdo, Hugo Cogo-Moreira, José Alberto Del Porto, Acioly Luiz Tavares de Lacerda, Andrea Parolin Jackowski
Publikováno v:
Journal of Affective Disorders Reports, Vol 3, Iss , Pp 100053- (2021)
Background: Ketamine is an effective antidepressant with a 65–70% response rate and a fast onset of action. Esketamine (S-ketamine) has been found to be twice as potent as R-ketamine, while inducing fewer adverse effects, such as sedation and cogni
Externí odkaz:
https://doaj.org/article/6bdb2fdfb5fa4fab98029273a326a99f
Autor:
Juliana Surjan, Julia Diniz Grossi, José Alberto Del Porto, Rodrigo Simonini Delfino, Raphael de Oliveira Cerqueira, Ana Cecília Lucchese, Eduardo Magalhães, Lorena Catarina Del Sant, Marco Aurélio Tuena, Carolina Nakahira, Victor Augusto Rodovalho Fava, Matheus Souza Steglich, Guilherme Lozi Abdo, Matheus Ghossain Barbosa, Luciana Maria Sarin, Acioly Luiz Tavares Lacerda
Publikováno v:
Clinical drug investigation. 42(10)
Affective disorders account for most cases of suicide. The pharmacological arsenal to treat suicidality is limited and available agents take too long to take effect. A large body of evidence shows optimal results of ketamine for treating depression,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83f0d61fb9cbd82908cd2aa36e35728
https://pubmed.ncbi.nlm.nih.gov/36044154
https://pubmed.ncbi.nlm.nih.gov/36044154
Autor:
José Alberto Del Porto, Acioly L.T. Lacerda, Guilherme Abdo, Matheus Ghossain Barbosa, Eduardo Magalhães, Lorena Catarina Del Sant, Ana Cecília Lucchese, Luciana Maria Sarin, Marco Aurélio Tuena, Aroldo Liberatori, Jair de Jesus Mari, Matheus Souza Steiglich, Frederico Molina Cohrs, Victor Augusto Rodovalho Fava, Juliana Surjan, Carolina Nakahira, Rodrigo Simonini Delfino
Publikováno v:
Journal of Psychopharmacology. 34:1155-1162
Introduction and objectives: The impact of multiple subcutaneous (s.c.) esketamine injections on the blood pressure (BP) and heart rate (HR) of patients with unipolar and bipolar treatment-resistant depression (TRD) is poorly understood. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f971995afeba06b76d1fc38c7fb332
https://doi.org/10.1177/0269881120922955
https://doi.org/10.1177/0269881120922955
Autor:
Juliana Surjan, Lorena Catarina Del Sant, Ana Cecília Lucchese, Rodrigo Simonini Delfino, Carolina Nakahira, Luciana Maria Sarin, Marco Aurélio Tuena, José Alberto Del Porto, Andrea Parolin Jackowski, Matheus Ghossain Barbosa, Acioly L.T. Lacerda, Matheus Souza Steglich, Guilherme Abdo, Eduardo Magalhães, Victor Augusto Rodovalho Fava, Hugo Cogo-Moreira, Camila Brito Puertas
Publikováno v:
Journal of Affective Disorders Reports, Vol 3, Iss, Pp 100053-(2021)
Background Ketamine is an effective antidepressant with a 65–70% response rate and a fast onset of action. Esketamine (S-ketamine) has been found to be twice as potent as R-ketamine, while inducing fewer adverse effects, such as sedation and cognit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8ec31501684ec50d9a1a9231039d5b
http://www.sciencedirect.com/science/article/pii/S2666915320300536
http://www.sciencedirect.com/science/article/pii/S2666915320300536
Autor:
Juliana Surjan, Lorena Catarina Del Sant, Ana Cecília Lucchese, Andrea Parolin Jackowski, Carolina Nakahira, Hugo Cogo-Moreira, Matheus Ghossain Barbosa, Guilherme Abdo, Acioly L.T. Lacerda, Rodrigo Simonini Delfino, Luciana Maria Sarin, Marco Aurélio Tuena, Matheus Souza Steiglich, Victor Augusto Rodovalho Fava, José Alberto Del Porto, Eduardo Magalhães
Publikováno v:
Revista de psiquiatria y salud mental.
Introduction The administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression (TRD). Nevertheless, the probability of responding or not after each dose in the real-world remains unknown. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3c436e3236f29157a0f20abfab4a77
https://pubmed.ncbi.nlm.nih.gov/33075541
https://pubmed.ncbi.nlm.nih.gov/33075541